International Research in Chinese Medicine

Objective To analyze the value of guizhi Tuckahoe Decoction in treating chronic pelvic inflammatory disease. Methods From January 2021 to March 2022, 96 patients with chronic pelvic inflammatory disease (N =96) were randomly divided into two groups: 48 patients in the experiment and 48 in the control group. The former received guizhifu decoction plus subtraction, and the latter received conventional treatment. Compare relapse rate and other indicators. Results The total effective rate of the experimental group was 97.92%, which was higher than that of the control group (83.33%) (P < 0.05). As for IL-2 and HS-CRP, at the end of the treatment course, the data of the experimental group were (5.97±0.94) ng/L and (4.05±0.91) mg/L, respectively, which were better than those of the control group (3.99±0.65) ng/L and (7.92±1.03) mg/L (P < 0.05). The recurrence rate of the experimental group was 2.08%, which was lower than that of the control group (18.75%) (P < 0.05). As for THE SF-36 score, at the end of treatment, the score of the experimental group was (90.36±2.57), which was higher than that of the control group (83.41±3.52) (P < 0.05). Conclusion Guizhiporia cocos decoction can reduce the recurrence rate, improve the serum inflammatory factors and improve the quality of life more rapidly.

Chronic pelvic inflammatory disease; The recurrence rate. Cassia twig and Poria cocos decoction; Inflammatory cytokines